How new food crops are being forced down Kenya's throat By: John Mbaria,
Special Correspondent,
The East African (July 9th edition)
An ongoing campaign to persuade
Kenyan farmers to grow genetically modified maize, cotton
and other crops has the blessings of key public bodies,
national research organizations and politicians and
is bankrolled by giant biotechnology multinationals
from the United States and elsewhere, investigations
by The EastAfrican have revealed.
The low-profile campaign has seen millions of dollars
from foreign sources being channelled into such national
scientific bodies as the Kenya Agricultural Research
Institute (KARI) as well as several not-for profit pro-GM
organizations and individual scientists.
Despite the fact that Kenya's chief outlet for horticulture
and other products, the European Union, remains totally
opposed to GMOs.
Members of Parliament have not been left out. The EastAfrican
has reliably learnt that the entire process of drafting
the Biosafety Bill (2005) was bankrolled by the external
agencies affiliated to giant biotechnology multinationals
who also organised an all-expenses paid trip for several
MPs to South Africa early last year.
The parliamentarians were taken on a guided tour of
the Makatini GM Cotton Project and other large-scale
projects in South Africa. Those who went included the
MP for Mwea, Alfred Nderitu, who later publicly supported
the introduction of GMOs in Kenya.
On the surface, most of these activities appear harmless.
Indeed, many biotechnology solutions represent novel
attempts to tackle the problems bedevilling agricultural
production and address the perennial food shortages
in the country. Pro-GM lobbyists claim that GM technology
is the answer to Africa's hunger.
For instance, a leading pro-GM campaigner, Dr Florence
Wambugu, has in the past told the media that GM can
literally banish hunger and famine from Africa. But
The EastAfrican has learnt that such claims about GM
crops are often exaggerated.
Take the case of a three-year experiment carried out
in Kenya by Dr Wambugu to develop virus-resistant sweet
potatoes. Funded by US-based biotechnology firm, Monsanto,
the project was hailed the world over as having offered
hope for "hungry Africa" even before its results
had started trickling in. But in a report in January
2004, the Daily Nation revealed that the project was
a flop.
"Trials to develop a virus-resistant sweet potato
through biotechnology have failed," the report
said.
A report published in the New Scientist on February
7 the same year said trials using traditional sweet
potato varieties in Uganda had performed better.
"Embarrassingly, in Uganda conventional breeding
has produced a high-yielding variety more quickly and
more cheaply," the report said.
That big money is involved in the campaign is not in
doubt. For instance, KARI's GM research — which is undertaken
jointly with the International Maize and Wheat Improvement
Centre — is funded in part by the Rockefeller Foundationand Syngenta Foundation for Sustainable Agriculture
to the tune of Ksh11.5 billion ($171.6 million).
In addition, a similar project dubbed Insect Resistant
Maize for Africa — a joint venture between the government
and international research institutes — had the bulk
of its Ksh450 million ($6.6 million) budget provided
by Syngenta and Rockefeller. It aimed at developing
a maize variety that is able to resist the stem borers
and distribute it to farmers by 2008.
The project came into the limelight with the official
opening of a $12 million greenhouse for GM maize trials
by President Mwai Kibaki in June 2004. But the government
abandoned the project and ordered the Kenya Plant Health
Inspectorate Service (Kephis) to destroy all the materials
for the trials in August 2005 after a technician reportedly
sprayed restricted pesticide to enable the maize resist
pests.
Syngenta Foundationis associated with a leading Swiss-based
agribusiness firm with an annual turnover of $8.1 billion
and a presence in 90 countries. Its local subsidiary,
Syngenta East Africa Ltd, is one of 59 seed companies
registered by Kephis.
Monsanto Kenya Ltd has meanwhile denied bankrolling
the drafting of the Biosafety Bill.
"We did not finance activities leading to the
making of the Bill," said the company's corporate
affairs director Kinyua Mbijjiwe.
However, small-scale Kenyan farmers have expressed
suspicions that the ongoing campaign to have the country
adopt GMOs is a subtle scheme by giant multinationals
to get them "hooked" to the latter's seeds
and anti-pest chemicals, thus creating a huge market
for them.
"This is a scheme to make us abandon our traditional
seed varieties so that we can be forever dependent on
the seeds and chemicals they manufacture," said
the treasurer of the Kenya Small Scale Farmers Forum
Justus Lavi.
There are also fears that the fact that it is the leading
economy in the region means that the pressure on Kenya
to accept GM crops is going to be particularly intense
as such acceptance will allow the multinationals to
get a foothold in the entire East And Central African
market.
Reports show that different biotechnology multinationals
have been bankrolling KARI to engage in open quarantine
tests of genetically modified cassava, maize, cotton
and sweet potatoes on their behalf.
Although Mr Mbijjiwe declined to say whether Monsanto
has financed the ongoing trials by KARI, reports say
the company's Danford Centre in the US, together with
the Syngenta Foundation, had financed KARI's GM maize,
cassava, sweet potatoes and cotton trials. These trials
have been okayed by the National Biosafety Committee.
Dr Daniel Maingi of ANAW Biotechnology Watch said the
ongoing trials combined with the campaign to have the
country's parliament pass the Biosafety Bill are the
prelude to a full scale introduction and propagation
of these crops in Kenya.
For Kenya, being rushed into introducing these crops
on a large scale could have unforeseen consequences
because, while globally it is not yet established whether
GMOs are safe, such public gatekeepers as Kephis lack
the capacity to put "firewalls" around local
engagement with these crops. Although attempts to bring
GMOs into the country began in the 1990s, Kephis only
set up a Ksh20 million ($298,000) laboratory to test
for such products recently. "The fact that we do
not have the capacity to test does not mean that these
companies bring genetically modified maize here,"
said Kephis chief executive Dr Chagema Kedera.
He added that Kephis relies on reports from regulatory
bodies of such countries as the US for information on
GM status of maize and other crops brought into Kenya
by multinational biotechnology firms.
But though Dr Kedera said Kephis does its own independent
tests — and has, at one point in the past been taken
to the World Trade Organisation (WTO) by US-based seed
companies for delaying the registration of some of their
seed varieties — doubts linger over its capacity to
test all the products entering the country through the
various points of entry.
"Moreover, it is possible that finished products
coming into the country could have transgenic traits,
but testing for this is beyond Kephis's mandate,"
Kedera said.
Much of Kenya's agricultural research is handled by
KARI, which has been involved in developing a series
of hybrid maize and other crop varieties since its inception.
But of late, KARI has taken to openly experimenting
with GM seed varieties of different crops brought in
by Monsanto and other companies.
Recently, KARI announced that it was about to release
into the market a GM maize variety that is resistant
to stem borer. The latter is a pest estimated to cause
losses of up to 15 per cent of the entire Kenyan maize
crop.
Besides GM maize, KARI has also been engaged in open
trials of sweet potatoes, cotton and sorghum varieties
in Kakamega in Western Kenya, Embu in Eastern Kenya
and other places. This has been taking place even though
the country has yet to put in place legal checks and
balances to regulate GM products.
There are fears that through wind action, the trials
could end up contaminating hybrid varieties of maize
in areas where KARI has been doing the trials.
This fear is reinforced by recent reports from Mexico
that the government there has announced that the DNA
of some wild varieties of maize in areas close to where
GM maize is grown had been found by researchers to possess
GM traits.
But Dr Kedera ruled out the contamination of hybrid
maize varieties by GM traits, saying Kephis has insisted
that the maize seedlings under test should not be allowed
to flower and that all trial materials be destroyed
to avoid any possibility of contamination. He told The
EastAfrican that Kephis had to order the termination
of trials that had been going on in Kiboko in Eastern
Kenya as the scientists involved "had not followed
the laid down regulations."
Genetic engineering is defined as the deliberate alteration
of plants' or animals' genetic makeup for purposes of
doing away with unwanted traits or to produce traits
that are desirable to biotech researchers. Such engineering
has the potential of raising productivity and helping
the plant cope with environmental or pest hazards.
In Kenya, the trials are conducted for the purpose
of producing crops resistant to striga (witch weed),
grain and stem borer and other pests.
Many of the genetically modified versions on trial
are said to be "armed" with the capacity to
withstand such pests or herbicides that kill striga
and other weeds.
While many scientists see nothing wrong with genetic
modification, there are those who say that science has
not fully grasped the implications of injecting "salien"
genes into edible plants and animals and prefer to approach
the matter with caution. Some, especially anti-GM activists,
see these experiments on "Frankenfoods" as
deeply evil and dangerous.
GM maize was first raised in 1997 in the US and Canada
and has since spread to about 21 million hectares with
over 50 per cent of the maize produced in the US being
modified to resist insects/pests or to tolerate herbicides.
|